This study highlights the clinical, pathological, and molecular complexity of HER2-mutated non-small-cell lung cancer (NSCLC) in a Brazilian cohort, providing valuable insights into a subset of tumors that pose significant diagnostic and therapeutic challenges. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.